Pravastatin improves survival in cardiac transplant recipients

In a study of 97 heart transplant recipients randomly assigned to pravastatin or placebo, survival at one year was significantly better with pravastatin (94 versus 78 percent).

Data from Kobashigawa JA, Katznelson S, Laks H, et al. N Engl J Med 1995; 333:621.

Graphic 66561 Version 2.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟